JointHealth™ express August 13, 2014
Reminder: Patient input on treatment for rheumatoid arthritis and ankylosing spondylitis needed
Do you have rheumatoid arthritis or ankylosing spondylitis or care for someone who does? We want your valuable input.
In July, Arthritis Consumer Experts sent out the following JointHealth™ expresses announcing that we are gathering patient input to submit to the Common Drug Review (CDR). Follow the links below to view the questions for each patient input request.
To help them make their recommendations, the CDR accepts input from patient groups, like Arthritis Consumer Experts (ACE). We would like to gather your views and share them with the CDR.
If you live with rheumatoid arthritis or ankylosing spondylitis or care for someone with the disease, please send us your input by Wednesday, August 20, 2014, so that we may submit a report by the August 28 deadline. Your input will be anonymous.
Please contact us at info@jointhealth.org to provide your input or arrange for a phone interview at 604-974-1366.
Reminder: Patient input on treatment for rheumatoid arthritis and ankylosing spondylitis needed
Do you have rheumatoid arthritis or ankylosing spondylitis or care for someone who does? We want your valuable input.
In July, Arthritis Consumer Experts sent out the following JointHealth™ expresses announcing that we are gathering patient input to submit to the Common Drug Review (CDR). Follow the links below to view the questions for each patient input request.
- Call for patient input on tofacitinib (Xeljanz®) for rheumatoid arthritis
- Call for patient input on subcutaneous tocilizumab (Actemra®) for rheumatoid arthritis
- Call for patient input on IV form of certolizumab pegol (Cimzia®) for ankylosing spondylitis
To help them make their recommendations, the CDR accepts input from patient groups, like Arthritis Consumer Experts (ACE). We would like to gather your views and share them with the CDR.
If you live with rheumatoid arthritis or ankylosing spondylitis or care for someone with the disease, please send us your input by Wednesday, August 20, 2014, so that we may submit a report by the August 28 deadline. Your input will be anonymous.
Please contact us at info@jointhealth.org to provide your input or arrange for a phone interview at 604-974-1366.
Arthritis Consumer Experts
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealth™ information and education programs.